"Thymidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nucleoside in which THYMINE is linked to DEOXYRIBOSE.
| Descriptor ID |
D013936
|
| MeSH Number(s) |
D03.383.742.680.705 D13.570.230.855 D13.570.685.705
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thymidine".
Below are MeSH descriptors whose meaning is more specific than "Thymidine".
This graph shows the total number of publications written about "Thymidine" by people in this website by year, and whether "Thymidine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2008 | 0 | 3 | 3 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 2 | 2 |
| 2012 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thymidine" by people in Profiles.
-
Tigano M, Phillips AF, Sfeir A. In Vivo Analysis of mtDNA Replication at the Single Molecule Level and with High Resolution. Methods Mol Biol. 2021; 2192:21-34.
-
Kalantari T, Kamali-Sarvestani E, Zhang GX, Safavi F, Lauretti E, Khedmati ME, Rostami A. Generation of large numbers of highly purified dendritic cells from bone marrow progenitor cells after co-culture with syngeneic murine splenocytes. Exp Mol Pathol. 2013 Apr; 94(2):336-42.
-
Bussard KM, Boulanger CA, Kittrell FS, Behbod F, Medina D, Smith GH. Immortalized, pre-malignant epithelial cell populations contain long-lived, label-retaining cells that asymmetrically divide and retain their template DNA. Breast Cancer Res. 2010; 12(5):R86.
-
Hann HW. Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses. Expert Opin Pharmacother. 2010 Sep; 11(13):2243-9.
-
Brody JR, Hucl T, Costantino CL, Eshleman JR, Gallmeier E, Zhu H, van der Heijden MS, Winter JM, Wikiewicz AK, Yeo CJ, Kern SE. Limits to thymidylate synthase and TP53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influence. Cancer Res. 2009 Feb 01; 69(3):984-91.
-
Raschke S, Guan J, Iliakis G. Application of alkaline sucrose gradient centrifugation in the analysis of DNA replication after DNA damage. Methods Mol Biol. 2009; 521:329-42.
-
Melstrom LG, Bentrem DJ, Salabat MR, Kennedy TJ, Ding XZ, Strouch M, Rao SM, Witt RC, Ternent CA, Talamonti MS, Bell RH, Adrian TA. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin Cancer Res. 2008 Oct 15; 14(20):6525-30.
-
Hann HW. Active antiviral therapy for chronic hepatitis B and hepatocellular carcinoma. Minerva Gastroenterol Dietol. 2008 Mar; 54(1):19-30.
-
Prasad A, Prasad KN, Yadav A, Gupta RK, Pradhan S, Jha S, Tripathi M, Husain M. Lymphocyte transformation test: a new method for diagnosis of neurocysticercosis. Diagn Microbiol Infect Dis. 2008 Jun; 61(2):198-202.
-
Lai CL, Leung N, Teo EK, Tong M, Wong F, Hann HW, Han S, Poynard T, Myers M, Chao G, Lloyd D, Brown NA. A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B. Gastroenterology. 2005 Aug; 129(2):528-36.